Product

Nexlizet

1 clinical trial

3 indications

Indication
Atherosclerosis
Clinical trial
Aggressive Risk-Prevention Therapies for Coronary Atherosclerotic Plaque (ART-CAP)
Status: Recruiting, Estimated PCD: 2029-01-31